Skip to main content Skip to navigation
We care about your privacy. Read about your rights and how we protect your data. Get Details

Coronavirus Update: What patients and families need to know

Targeted therapies against neuroblastoma


Dai Chung, M.D., discusses ongoing cancer biology laboratory investigative efforts to gain molecular insights that may allow for new targeted therapies against high-risk neuroblastomas and ultimately more effectively treat pediatric patients with this devastating cancer.

Neuroblastomas remain as one of the most difficult pediatric extracranial solid tumor to treat due to its refractoriness to multimodal treatment and/or frequent recurrent disease, especially in high-risk group. Despite intense basic scientific and translational discovery efforts spanning over the past several decades, the exact understanding of tumor biology of this enigmatic pediatric cancer remains elusive. However, on-going cancer biology laboratory investigative efforts to gain molecular insights may allow us to develop novel targeted therapies against high-risk neuroblastomas and ultimately more effectively treat pediatric patients with this devastating cancer.

Invest in future cures for some of life's most devastating diseases

See other ways to give

Share your birthday with a child. Celebrate your life, and give a chance to someone who desperately wants to have as many as you.

Share your birthday with a child. Celebrate your life, and give a chance to someone who desperately wants to have as many as you. Make it happen